HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,367 | -9.4% | 37,596 | -13.9% | 0.00% | 0.0% |
| Q2 2023 | $3,717 | +18.1% | 43,655 | +14.7% | 0.00% | +100.0% |
| Q1 2023 | $3,148 | +78.1% | 38,049 | +69.3% | 0.00% | 0.0% |
| Q4 2022 | $1,768 | -99.6% | 22,477 | +271.5% | 0.00% | – |
| Q3 2022 | $447,000 | +54.7% | 6,050 | +36.4% | 0.00% | – |
| Q2 2022 | $289,000 | -62.8% | 4,436 | -63.8% | 0.00% | -100.0% |
| Q1 2022 | $776,000 | -90.2% | 12,258 | -91.8% | 0.00% | 0.0% |
| Q4 2021 | $7,902,000 | +95.7% | 148,986 | +160.5% | 0.00% | -50.0% |
| Q3 2021 | $4,038,000 | +59.0% | 57,200 | +50.1% | 0.00% | +100.0% |
| Q2 2021 | $2,539,000 | -9.9% | 38,116 | +50.1% | 0.00% | -50.0% |
| Q1 2021 | $2,819,000 | +1588.0% | 25,399 | +1706.5% | 0.00% | – |
| Q4 2020 | $167,000 | +6.4% | 1,406 | -21.5% | 0.00% | – |
| Q3 2020 | $157,000 | -90.3% | 1,791 | -90.1% | 0.00% | -100.0% |
| Q2 2020 | $1,614,000 | -16.4% | 18,030 | -6.9% | 0.00% | -50.0% |
| Q1 2020 | $1,931,000 | -71.7% | 19,365 | -67.4% | 0.00% | -50.0% |
| Q4 2019 | $6,825,000 | +52.3% | 59,410 | +67.2% | 0.00% | +33.3% |
| Q3 2019 | $4,481,000 | -8.7% | 35,530 | -12.8% | 0.00% | 0.0% |
| Q2 2019 | $4,906,000 | +23.3% | 40,768 | -10.3% | 0.00% | 0.0% |
| Q1 2019 | $3,978,000 | +183.1% | 45,470 | +223.7% | 0.00% | +200.0% |
| Q4 2018 | $1,405,000 | -70.9% | 14,049 | -66.6% | 0.00% | -66.7% |
| Q3 2018 | $4,825,000 | -43.7% | 42,113 | -56.0% | 0.00% | -62.5% |
| Q2 2018 | $8,575,000 | +582.7% | 95,618 | +457.1% | 0.01% | +700.0% |
| Q1 2018 | $1,256,000 | +89.2% | 17,165 | +50.1% | 0.00% | 0.0% |
| Q4 2017 | $664,000 | +370.9% | 11,436 | +264.0% | 0.00% | – |
| Q3 2017 | $141,000 | -73.2% | 3,142 | -76.4% | 0.00% | -100.0% |
| Q2 2017 | $527,000 | +824.6% | 13,329 | +850.7% | 0.00% | – |
| Q1 2017 | $57,000 | +23.9% | 1,402 | +22.2% | 0.00% | – |
| Q4 2016 | $46,000 | -41.8% | 1,147 | -47.7% | 0.00% | – |
| Q3 2016 | $79,000 | -37.3% | 2,194 | -49.6% | 0.00% | – |
| Q2 2016 | $126,000 | -90.9% | 4,356 | -89.3% | 0.00% | -100.0% |
| Q1 2016 | $1,384,000 | +517.9% | 40,697 | +482.8% | 0.00% | – |
| Q4 2015 | $224,000 | +1078.9% | 6,983 | +1033.6% | 0.00% | – |
| Q3 2015 | $19,000 | -52.5% | 616 | -37.9% | 0.00% | – |
| Q2 2015 | $40,000 | -43.7% | 992 | -39.3% | 0.00% | – |
| Q1 2015 | $71,000 | -34.9% | 1,633 | -44.9% | 0.00% | – |
| Q4 2014 | $109,000 | +70.3% | 2,964 | +57.0% | 0.00% | – |
| Q3 2014 | $64,000 | +100.0% | 1,888 | +104.1% | 0.00% | – |
| Q2 2014 | $32,000 | -54.3% | 925 | -57.7% | 0.00% | – |
| Q1 2014 | $70,000 | -91.6% | 2,188 | -89.0% | 0.00% | -100.0% |
| Q4 2013 | $836,000 | -55.7% | 19,925 | -58.8% | 0.00% | -50.0% |
| Q3 2013 | $1,888,000 | -36.9% | 48,380 | -33.1% | 0.00% | -50.0% |
| Q2 2013 | $2,991,000 | – | 72,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |